Clinical trial
Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer
NCT00212082 · National University Hospital, Singapore, Other · Completed
Key facts
| NCT number | NCT00212082 |
|---|---|
| Title | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer |
| Official title | Gene Expression Profiles of Breast Cancer Treated With Sequential Adriamycin and Docetaxel in Relation to Tumor Responses |
| Lead sponsor | National University Hospital, Singapore, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | doxorubicin, docetaxel |
| Enrollment | 100 |
| Start date | Apr 1, 2002 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 12, 2008 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: